SCHEMBL4546786

SCHEMBL4546786

C[N+]1(CCCCCCBr)CCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
KMT2A Q03164 2/20 0.50
BBOX1 O75936 2/20 0.47
APOBEC3A P31941 2/20 0.46
APOBEC3G Q9HC16 2/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
KDM4E B2RXH2 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.38
FOXM1 Q08050 4/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
GNAI3 P08754 1/20 0.34
GNAO1 P09471 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4546781 1.00 LMNA (0.50) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G
SCHEMBL14924316 0.98 LMNA (0.53) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G
SCHEMBL29112841 0.98 LMNA (0.53) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G
Bromide SCHEMBL31452230 0.98 LMNA (0.49) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G
SCHEMBL29719599 0.98 LMNA (0.53) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G
Bromide SCHEMBL14914113 0.96 LMNA (0.51) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G
Bromide SCHEMBL28639847 0.96 LMNA (0.51) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G
SCHEMBL14863930 0.95 LMNA (0.50) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G
Bromide SCHEMBL14915227 0.93 LMNA (0.49) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G
SCHEMBL14734616 0.90 BBOX1 (0.50) LMNAKMT2ABBOX1APOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743439-A1 IONIC ORGANIC COMPOUNDS, COMPOSITIONS AND ELECTROLYTES COMPRISING SAME, AND USE THEREOF IN ELECTROCHEMISTRY Hydro-Québec (CA) 2026-05-20 EP claimed
WO-2025015411-A1 IONIC ORGANIC COMPOUNDS, COMPOSITIONS AND ELECTROLYTES COMPRISING SAME, AND USE THEREOF IN ELECTROCHEMISTRY HYDRO-QUéBEC (CA) 2025-01-23 WO claimed
EP-4743439-A1 IONIC ORGANIC COMPOUNDS, COMPOSITIONS AND ELECTROLYTES COMPRISING SAME, AND USE THEREOF IN ELECTROCHEMISTRY Hydro-Québec (CA) 2026-05-20 EP disclosed
WO-2025015411-A1 IONIC ORGANIC COMPOUNDS, COMPOSITIONS AND ELECTROLYTES COMPRISING SAME, AND USE THEREOF IN ELECTROCHEMISTRY HYDRO-QUéBEC (CA) 2025-01-23 WO disclosed
US-9782746-B2 Polymeric ionic liquids, methods of making and methods of use thereof THE UNIVERSITY OF TOLEDO (US) 2017-10-10 US disclosed
US-9782746-B2 Polymeric ionic liquids, methods of making and methods of use thereof THE UNIVERSITY OF TOLEDO (US) 2017-10-10 US disclosed
US-20160114309-A1 Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof THE UNIVERSITY OF TOLEDO (US) 2016-04-28 US disclosed
US-20160114309-A1 Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof THE UNIVERSITY OF TOLEDO (US) 2016-04-28 US disclosed
US-9249261-B2 Polymeric ionic liquids, methods of making and methods of use thereof THE UNIVERSITY OF TOLEDO (US) 2016-02-02 US disclosed
US-9249261-B2 Polymeric ionic liquids, methods of making and methods of use thereof THE UNIVERSITY OF TOLEDO (US) 2016-02-02 US disclosed
US-8956445-B2 High stability diionic liquid salts SIGMA-ALDRICH CO. (US) 2015-02-17 US disclosed
US-20120211696-A1 HIGH STABILITY DIIONIC LIQUID SALTS SIGMA-ALDRICH CO. LLC (US) 2012-08-23 US disclosed
US-20120211696-A1 HIGH STABILITY DIIONIC LIQUID SALTS SIGMA-ALDRICH CO. LLC (US) 2012-08-23 US disclosed
US-20120111796-A1 Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof UNIVERSITY OF TOLEDO (US) 2012-05-10 US disclosed
US-20120111796-A1 Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof UNIVERSITY OF TOLEDO (US) 2012-05-10 US disclosed
US-8168830-B2 use of these novel ionic liquids having bis-cation or bis-anion separated by bridging group as the stationary phase in a gas chromatographic column SIGMA-ALDRICH CO. LLC (US) 2012-05-01 US disclosed
US-8168830-B2 use of these novel ionic liquids having bis-cation or bis-anion separated by bridging group as the stationary phase in a gas chromatographic column SIGMA-ALDRICH CO. LLC (US) 2012-05-01 US disclosed
US-20110236295-A1 Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof UNIVERSITY OF TOLEDO (US) 2011-09-29 US disclosed
US-20080027231-A1 High stability diionic liquid salts SIGMA-ALDRICH CO. (US) 2008-01-31 US disclosed
US-20080027231-A1 High stability diionic liquid salts SIGMA-ALDRICH CO. (US) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027231-A1 High stability diionic liquid salts H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDHD5, DAD1 LMNA 739/4885KMT2A 3995/4885BBOX1 4134/4885
US-20120111796-A1 Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof BCCIP, SLC6A12, BOLA2; BOLA2B LMNA 584/4885KMT2A 3451/4885BBOX1 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.